Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Will handle active and passive temperature-controlled pharmaceutical products
World Health Organisation to fund the project
As manufacturers look to provide treatments for the long-term management of increasingly complex diseases and medical conditions, Cambridge Consultants discusses the role of design in meeting the needs of an ageing population and the trend towards self-medication by patients at home
India envisages exports expansion in Latin America and places renewed focus and investment on safeguarding the quality of drugs produced
The timber-framed building could not be saved
Water's relationship to APIs is complex and can spell disaster for some drug formulations. Andrew Parker, Molecular Profiles, and Michael Leane, Bristol-Myers Squibb, look at the need to control relative humidity during various production processes
To increase access to hepatitis C drugs in 91 developing countries
The complexity of dry powder inhalers makes them one of the toughest generic development targets. Dr Paul Kippax, Malvern Instruments, reviews FDA guidance on their formulation and discusses strategies for effective de-formulation
To increase its fill finish capabilities
Nasal MDIs have the potential to reach far beyond the current usage sphere of allergic rhinitis. Louise Righton, Global Marketing Operations Manager, 3M Drug Delivery Systems, looks at why they may see wider therapy use in future
EMA receives views of 24 industry organisations
Drug formulators will have a broader range of drug delivery options in future, aiding both compliance and outcomes. Susan Birks reports